Clinical Trial Update: Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pembrolizumab in combination with intratumoral injection of Clostridium novyi-NT across multiple cancer types; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Breast Cancer
• Gastrointestinal Cancers
• Gynecologic Cancer
• Head and Neck Cancer
• Male Genital Organ Cancer
• Soft Tissue Sarcoma
• Urinary Tract Cancer

Drugs mentioned

• Clostridium novyi-NT
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Status: ACTIVE_NOT_RECRUITING